Haiqi Lu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
Papers in
-
- Epigenetics and DNA Methylation 7
- Histone Deacetylase Inhibitors Research 4
- Kruppel-like factors research 3
- Ubiquitin and proteasome pathways 2
- Circular RNAs in diseases 2
- Oncology 6
- Cancer Cells and Metastasis 3
- Co-authors
- Xian Wang (17 shared papers)Hongchuan Jin (15 shared papers)Huiyin Lan (2 shared papers)Lifeng Feng (12 shared papers)Jie Sun (7 shared papers)Leiming Liu (4 shared papers)Guangliang Li (2 shared papers)Qi Shen (5 shared papers)
- Journals
- Journal of Molecular Medicine (2 papers)FEBS Letters (2 papers)Oncotarget (2 papers)Autophagy (2 papers)BioMed Research International (1 paper)
- Partner nations
- ChinaGermanyNew Zealand
In The Last Decade
Haiqi Lu
21 papers receiving 907 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 367
- Molecular Biology 561
- Nephrology 54
- Epidemiology 139
- Oncology 96
Countries citing papers authored by Haiqi Lu
This map shows the geographic impact of Haiqi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiqi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiqi Lu more than expected).
Fields of papers citing papers by Haiqi Lu
This network shows the impact of papers produced by Haiqi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiqi Lu. The network helps show where Haiqi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Haiqi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 276 | |
| 2 | 2013 | 90 | |
| 3 | Klotho is silenced through promoter hypermethylation in gastric cancer. | 2010 | 77 |
| 4 | 2013 | 70 | |
| 5 | 2014 | 62 | |
| 6 | 2023 | 48 | |
| 7 | Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development. | 2016 | 41 |
| 8 | 2012 | 36 | |
| 9 | 2012 | 31 | |
| 10 | Annexin A6 is down-regulated through promoter methylation in gastric cancer. | 2013 | 28 |
| 11 | 2019 | 27 | |
| 12 | 2013 | 26 | |
| 13 | 2017 | 26 | |
| 14 | 2017 | 20 | |
| 15 | 2011 | 16 | |
| 16 | 2014 | 15 | |
| 17 | 2021 | 10 | |
| 18 | 2015 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2009 | 4 |
About Haiqi Lu
Haiqi Lu is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 916 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Histone Deacetylase Inhibitors Research (4 papers), MicroRNA in disease regulation (4 papers), Kruppel-like factors research (3 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (2 papers), Ubiquitin and proteasome pathways (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (367 citations), Molecular Biology (561 citations), Nephrology (54 citations), Epidemiology (139 citations) and Oncology (96 citations). Haiqi Lu has collaborated with scholars based in China, Germany and New Zealand. Frequent co-authors include Xian Wang, Hongchuan Jin, Huiyin Lan, Lifeng Feng, Jie Sun, Leiming Liu, Guangliang Li, Qi Shen, Xiaoying Lin and Jun Yu. Their work appears in journals such as Journal of Molecular Medicine, FEBS Letters, Oncotarget, Autophagy and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.